# Receptos Services

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/receptos-services

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.receptos.com
- Total disclosed funding: $69M
- Latest round: Series B (Mar 27, 2013)
- Investors on record: 7

## About

Receptos Services LLC, based in the US, operates as a biopharmaceutical company focused on developing and commercializing innovative therapies in various therapeutic areas, providing crucial health solutions to patients and healthcare providers.Receptos Services LLC specializes in biopharmaceutical development, founded with a focus on innovative medicines. The company is headquartered in San Diego, US. In May 2013, Receptos raised USD 72.8 mn in its IPO, selling 5.2 million shares at USD 14 per share. The funding attracted investor interest as part of the offering. The founder's history details, including previous ventures, are not available.Receptos Services LLC focuses on developing advanced therapies for complex health challenges, with an emphasis on oncology, immunology, and cardiovascular diseases. The company’s offerings are designed to meet the needs of healthcare providers, hospitals, and oncology clinics, ensuring accessibility to patients in critical conditions.In 2014, Receptos reported a revenue of USD 5.90 mn, while the EBITDA for the same year was USD -109.29 mn, reflecting the company's financial performance during that period.Receptos Services LLC plans to utilize the USD 72.8 mn raised in its IPO to support the launch of new products and expansion into new markets. The focus will be on enhancing their therapeutic offerings and geographical outreach, with specific growth targets and timelines yet to be disclosed.

## Funding rounds

- Series B, Mar 27, 2013, $5M — Polaris Partners
- Series B, Feb 18, 2012, $11M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners, Lilly Ventures, Venrock
- Series A, Nov 23, 2009, $25M — ARCH Venture Partners, Flagship Pioneering, Lilly Ventures, Venrock
- Series A, Apr 8, 2008, $20M — Advanced Technology Ventures, ARCH Venture Partners, OrbiMed Advisors, Venrock
- Series A, Feb 13, 2008, $7.9M — Advanced Technology Ventures, ARCH Venture Partners, OrbiMed Advisors, Venrock

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series A
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series A, Series B
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series B